Key facts
- Researchers discovered different flu strains use distinct strategies to infiltrate human cells.
- Targeting specific molecules can block viral entry and halt replication.
- H3N2 viruses require the human protein Rab11B to enter lung cells, while H1N1 viruses are unaffected.
- This discovery challenges the assumption that all flu viruses enter cells the same way.
- Further research is needed to determine safety and effectiveness in a live human respiratory system.
An accidental laboratory discovery has revealed new potential methods for preventing the flu. Researchers investigating influenza replication found that different flu strains employ unique strategies to infiltrate human cells. By identifying and targeting the specific molecules these viruses rely on, scientists have demonstrated the ability to block viral entry into new cells and halt their replication. This breakthrough challenges the long-held scientific assumption that all flu viruses enter cells in the same manner.
The study, published in The Journal of Virology, focused on H1N1 and H3N2 influenza A viruses. The research team unexpectedly identified a cellular pathway involving a human protein called Rab11B. They found that when Rab11B was depleted, H3N2 viruses were unable to enter human lung cells, while H1N1 viruses remained unaffected. This indicates a specific role for Rab11B in the entry mechanism of H3N2.
Principal investigator Dr. Emily Bruce stated that these "fundamental insights" into seasonal influenza provide a clear direction for developing improved preventive medications. The hope is that this curiosity-driven research will lead to novel strategies for treating and preventing influenza infections, addressing the "dire" need for better medications to curb the virus's spread. However, the researchers acknowledge that the study was conducted using isolated cells, and further research is necessary to confirm the safety and effectiveness of these findings within a complete human respiratory system.